ZTS - Zoetis Inc.

125.93
-3.030   -2.406%

Share volume: 3,049,953
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%
$128.96
-3.03
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
79%
Profitability 81%
Dept financing 47%
Liquidity 48%
Performance 93%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.94%
1 Month
-0.61%
3 Months
4.58%
6 Months
-17.80%
1 Year
-25.88%
2 Year
-32.97%
Key data
Stock price
$125.93
P/E Ratio 
20.66
DAY RANGE
$125.18 - $127.90
EPS 
$6.03
52 WEEK RANGE
$115.25 - $177.00
52 WEEK CHANGE
-$24.59
MARKET CAP 
55.212 B
YIELD 
1.60%
SHARES OUTSTANDING 
422.128 M
DIVIDEND
$0.53
EX-DIVIDEND DATE
04-20-2026
NEXT EARNINGS DATE
08-05-2025
BETA 
0.19
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,666,377
AVERAGE 30 VOLUME 
$4,545,262
Company detail
CEO: Kristin C. Peck
Region: US
Website: zoetis.com
Employees: 13,800
IPO year: 2013
Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts.

Recent news